Projects

ADAM: Advancing DiAbetes Management - Integration of Continuous Glucose Monitoring with Artificial Intelligence for Personalized Diet Interventions in Diabetes.

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2027

Project Lead

Dr. Anjali T M Ollapally

Authors

Dr. Anjali T M Ollapally, Dr. Shruthi Kulkarni,Dr. Tinku Thomas, Dr. Anura V Kurpad,

Project Status

ongoing

Project Type

ICMR extamural small grant